Drug
IGF-1
IGF-1 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
2
50%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 21 (25.0%)
N/A2 (50.0%)
Trials by Status
terminated125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
NMES Effects on Substrate Metabolism and IGF-1
NCT06850532
terminatedphase_2
A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
NCT01970345
completednot_applicable
A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)
NCT05612802
completedphase_1
Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy
NCT01207908
Clinical Trials (4)
Showing 4 of 4 trials
NCT06850532Not Applicable
NMES Effects on Substrate Metabolism and IGF-1
NCT01970345Phase 2
A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
NCT05612802Not Applicable
A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)
NCT01207908Phase 1
Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4